Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Jianjun Zou
Introduction
Jianjun Zou is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of medicine, particularly in the treatment of gastric cancer. His innovative approach combines different therapeutic agents to enhance treatment efficacy.
Latest Patents
Jianjun Zou holds a patent for the "Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer." This patent describes a novel combination of a VEGFR inhibitor and a PARP inhibitor, which can be utilized in the preparation of a medicament specifically aimed at treating gastric cancer.
Career Highlights
Jianjun Zou is associated with Jiangsu Hengrui Medicine Company Ltd., a leading pharmaceutical company in China. His work at this company has allowed him to focus on developing innovative treatments that address critical health issues.
Collaborations
Jianjun Zou has collaborated with notable colleagues, including Jiahua Jiang and Guoqing Cao. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Jianjun Zou's contributions to medical innovation, particularly in cancer treatment, highlight the importance of combining different therapeutic strategies. His work continues to pave the way for advancements in the field of oncology.